isoproterenol and arginyl-glycyl-aspartyl-serine

isoproterenol has been researched along with arginyl-glycyl-aspartyl-serine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armstead, WM; Cines, DB; Higazi, AA; Kiessling, JW	1

Other Studies

1 other study(ies) available for isoproterenol and arginyl-glycyl-aspartyl-serine

Article	Year
Inhibition of integrin alphavbeta3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:3 Topics: Adrenergic beta-Agonists; Animals; Animals, Newborn; Antibodies; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypercapnia; Hypotension; Hypoxia-Ischemia, Brain; Integrin alphaVbeta3; Isoproterenol; Male; Oligopeptides; Peptides; Peptides, Cyclic; Signal Transduction; Swine; Urokinase-Type Plasminogen Activator; Vasoconstriction; Vasodilation	2009

Article

Year

Inhibition of integrin alphavbeta3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia.

American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:3

Topics: Adrenergic beta-Agonists; Animals; Animals, Newborn; Antibodies; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypercapnia; Hypotension; Hypoxia-Ischemia, Brain; Integrin alphaVbeta3; Isoproterenol; Male; Oligopeptides; Peptides; Peptides, Cyclic; Signal Transduction; Swine; Urokinase-Type Plasminogen Activator; Vasoconstriction; Vasodilation

2009